BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oda Y, Mizutani K, Hase I, Nakamoto T, Hamaoka N, Asada A. Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro. Br J Anaesth. 1999;82:900-903. [PMID: 10562786 DOI: 10.1093/bja/82.6.900] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Peters JW, Anderson BJ, Simons SH, Uges DR, Tibboel D. Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates. Clin Pharmacokinet 2006;45:705-14. [PMID: 16802851 DOI: 10.2165/00003088-200645070-00005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
2 Yang LQ, Li SJ, Cao YF, Man XB, Yu WF, Wang HY, Wu MC. Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. World J Gastroenterol 2003; 9(2): 359-363 [PMID: 12532467 DOI: 10.3748/wjg.v9.i2.359] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
3 Skrobik Y. Counterpoint: should benzodiazepines be avoided in mechanically ventilated patients? No. Chest 2012;142:284-7. [PMID: 22871751 DOI: 10.1378/chest.12-1191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
4 Yang LQ, Yu WF, Cao YF, Gong B, Chang Q, Yang GS. Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol 2003; 9(9): 1959-1962 [PMID: 12970884 DOI: 10.3748/wjg.v9.i9.1959] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
5 Lotsch J, Skarke C, Tegeder I, Geisslinger G. Drug Interactions with Patient-Controlled Analgesia: . Clinical Pharmacokinetics 2002;41:31-57. [DOI: 10.2165/00003088-200241010-00004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
6 Ishiwata Y, Nagata M, Kiuchi S, Ippongi C, Takeda H, Takahashi H. Intravenous Infusion of Fentanyl Has No Effect on Blood Concentration of Tacrolimus in Patients Receiving Hematopoietic Stem-Cell Transplantation. Ther Drug Monit 2021;43:688-91. [PMID: 33298744 DOI: 10.1097/FTD.0000000000000853] [Reference Citation Analysis]
7 Cheng J, Wang S, Lin W, Wu N, Wang Y, Chen M, Xie XQ, Feng Z. Computational Systems Pharmacology-Target Mapping for Fentanyl-Laced Cocaine Overdose. ACS Chem Neurosci 2019;10:3486-99. [PMID: 31257858 DOI: 10.1021/acschemneuro.9b00109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
8 Sachs B, Erdmann S, Al-masaoudi T, Merk H. In vitro drug allergy detection system incorporating human liver microsomes in chlorazepate-induced skin rash: drug-specific proliferation associated with interleukin-5 secretion. Br J Dermatol 2001;144:316-20. [DOI: 10.1046/j.1365-2133.2001.04021.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
9 Moody DE. Drug Interactions with Benzodiazepines. In: Mozayani A, Raymon LP, editors. Handbook of Drug Interactions. Totowa: Humana Press; 2004. pp. 3-88. [DOI: 10.1007/978-1-59259-654-6_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Hamaoka N, Oda Y, Hase I, Asada A. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies. British Journal of Anaesthesia 2001;86:540-4. [DOI: 10.1093/bja/86.4.540] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
11 Shen M, Chen M, Liang T, Wang S, Xue Y, Bertz R, Xie XQ, Feng Z. Pain Chemogenomics Knowledgebase (Pain-CKB) for Systems Pharmacology Target Mapping and Physiologically Based Pharmacokinetic Modeling Investigation of Opioid Drug-Drug Interactions. ACS Chem Neurosci 2020;11:3245-58. [PMID: 32966035 DOI: 10.1021/acschemneuro.0c00372] [Reference Citation Analysis]
12 de Wildt SN, de Hoog M, Vinks AA, van der Giesen E, van den Anker JN. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients: . Critical Care Medicine 2003;31:1952-8. [DOI: 10.1097/01.ccm.0000084806.15352.da] [Cited by in Crossref: 93] [Cited by in F6Publishing: 69] [Article Influence: 5.2] [Reference Citation Analysis]
13 English BA, Dortch M, Ereshefsky L, Jhee S. Clinically significant psychotropic drug-drug interactions in the primary care setting. Curr Psychiatry Rep 2012;14:376-90. [PMID: 22707017 DOI: 10.1007/s11920-012-0284-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
14 Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL. Coronary Artery Stents: II. Perioperative Considerations and Management. Anesthesia & Analgesia 2008;107:570-90. [DOI: 10.1213/ane.0b013e3181731e95] [Cited by in Crossref: 74] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
15 Mc Donnell CG, Shorten G, Van Pelt FNAM. Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro. Anaesthesia 2005;60:747-53. [DOI: 10.1111/j.1365-2044.2005.04110.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
16 Lee MD, Ayanoglu E, Gong L. Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions. Xenobiotica 2006;36:1013-80. [PMID: 17118918 DOI: 10.1080/00498250600861785] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
17 Howgate EM, Rowland Yeo K, Proctor NJ, Tucker GT, Rostami-Hodjegan A. Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability. Xenobiotica 2006;36:473-97. [PMID: 16769646 DOI: 10.1080/00498250600683197] [Cited by in Crossref: 159] [Cited by in F6Publishing: 143] [Article Influence: 10.6] [Reference Citation Analysis]
18 Shiran MR, Proctor NJ, Howgate EM, Rowland-Yeo K, Tucker GT, Rostami-Hodjegan A. Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling. Xenobiotica 2006;36:567-80. [PMID: 16864504 DOI: 10.1080/00498250600761662] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
19 Ziesenitz VC, König SK, Mahlke NS, Skopp G, Haefeli WE, Mikus G. Pharmacokinetic interaction of intravenous fentanyl with ketoconazole. J Clin Pharmacol 2015;55:708-17. [PMID: 25651378 DOI: 10.1002/jcph.469] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
20 Moody DE. Drug Interactions with Benzodiazepines: Epidemiologic Correlates with Other CNS Depressants and In Vitro Correlates with Inhibitors and Inducers of Cytochrome P450 3A4. In: Mozayani A, Raymon L, editors. Handbook of Drug Interactions. Totowa: Humana Press; 2012. pp. 25-116. [DOI: 10.1007/978-1-61779-222-9_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 Nakayama S, Miyabe M, Kakiuchi Y, Inomata S, Osaka Y, Fukuda T, Kohda Y, Toyooka H. Propofol Does Not Inhibit Lidocaine Metabolism During Epidural Anesthesia: . Anesthesia & Analgesia 2004;99:1131-5. [DOI: 10.1213/01.ane.0000131508.39939.86] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
22 Bremer F, Reulbach U, Schwilden H, Sch??ttler J. Midazolam Therapeutic Drug Monitoring in Intensive Care Sedation: A 5-Year Survey. Therapeutic Drug Monitoring 2004;26:643-9. [DOI: 10.1097/00007691-200412000-00010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
23 Palmer RB. Fentanyl in postmortem forensic toxicology. Clinical Toxicology 2010;48:771-84. [DOI: 10.3109/15563650.2010.525514] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
24 Edginton AN, Schmitt W, Voith B, Willmann S. A Mechanistic Approach for the Scaling of Clearance in Children: . Clinical Pharmacokinetics 2006;45:683-704. [DOI: 10.2165/00003088-200645070-00004] [Cited by in Crossref: 154] [Cited by in F6Publishing: 140] [Article Influence: 10.3] [Reference Citation Analysis]
25 El-Solh AA. Clinical approach to the critically ill, morbidly obese patient. Am J Respir Crit Care Med 2004;169:557-61. [PMID: 14982823 DOI: 10.1164/rccm.200309-1256CC] [Cited by in Crossref: 57] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
26 Brill MJ, Diepstraten J, van Rongen A, van Kralingen S, van den Anker JN, Knibbe CA. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet 2012;51:277-304. [PMID: 22448619 DOI: 10.2165/11599410-000000000-00000] [Cited by in Crossref: 204] [Cited by in F6Publishing: 177] [Article Influence: 22.7] [Reference Citation Analysis]
27 Zaporowska-Stachowiak I, Szymański K, Oduah MT, Stachowiak-Szymczak K, Łuczak J, Sopata M. Midazolam: Safety of use in palliative care: A systematic critical review. Biomed Pharmacother 2019;114:108838. [PMID: 30981104 DOI: 10.1016/j.biopha.2019.108838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
28 Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 2002;34:83-448. [DOI: 10.1081/dmr-120001392] [Cited by in Crossref: 558] [Cited by in F6Publishing: 143] [Article Influence: 29.4] [Reference Citation Analysis]
29 Kaneko K, Suzuki K, Iwadate-iwata E, Kato I, Uchida K, Onoue M. Evaluation of Food-drug Interaction of Guava Leaf Tea: EVALUATION OF FOOD-DRUG INTERACTION OF GUAVA LEAF TEA. Phytother Res 2013;27:299-305. [DOI: 10.1002/ptr.4724] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
30 Bolon M, Boulieu R, Flamens C, Paulus S, Bastien O. Sédation par le midazolam en réanimation : aspects pharmacologiques et pharmacocinétiques. Annales Françaises d'Anesthésie et de Réanimation 2002;21:478-92. [DOI: 10.1016/s0750-7658(02)00662-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
31 Petzold A, Girbes A. Pain Management in Neurocritical Care. Neurocrit Care 2013;19:232-56. [DOI: 10.1007/s12028-013-9851-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Kos MK, Miksić M, Jovanović M, Roškar R, Grosek Š, Grabnar I. Maturation of midazolam clearance in critically ill children with severe bronchiolitis: A population pharmacokinetic analysis. Eur J Pharm Sci 2020;141:105095. [PMID: 31626965 DOI: 10.1016/j.ejps.2019.105095] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Geile J, Maas A, Kraemer M, Doberentz E, Madea B. Fatal misuse of transdermal fentanyl patches. Forensic Sci Int 2019;302:109858. [PMID: 31279508 DOI: 10.1016/j.forsciint.2019.06.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
34 Ogawa R, Stachnik JM, Echizen H. Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 2, Drugs Administered Orally). Clin Pharmacokinet 2014;53:1083-114. [DOI: 10.1007/s40262-014-0189-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
35 Sweeney BP, Bromilow J. Liver enzyme induction and inhibition: implications for anaesthesia. Anaesthesia 2006;61:159-77. [PMID: 16430569 DOI: 10.1111/j.1365-2044.2005.04462.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
36 Oda Y, Hamaoka N, Hiroi T, Imaoka S, Hase I, Tanaka K, Funae Y, Ishizaki T, Asada A. Involvement of human liver cytochrome P4502B6 in the metabolism of propofol. Br J Clin Pharmacol. 2001;51:281-285. [PMID: 11298076 DOI: 10.1046/j.1365-2125.2001.00344.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
37 Nies RJ, Müller C, Pfister R, Binder PS, Nosseir N, Nettersheim FS, Kuhr K, Wiesen MHJ, Kochanek M, Michels G. Monitoring of sedation depth in intensive care unit by therapeutic drug monitoring? A prospective observation study of medical intensive care patients. J Intensive Care 2018;6:62. [PMID: 30302254 DOI: 10.1186/s40560-018-0331-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
38 Lötsch J, Walter C, Parnham MJ, Oertel BG, Geisslinger G. Pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet 2013;52:23-36. [PMID: 23100195 DOI: 10.1007/s40262-012-0016-7] [Cited by in Crossref: 68] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]